INTERFERON ANTIBODIES IN PATIENTS WITH CHRONIC HBV INFECTION TREATED WITH RECOMBINANT INTERFERON

被引：76

作者：

PORRES, JC

CARRENO, V

RUIZ, M

MARRON, JA

BARTOLOME, J

机构：

[1] FDN JIMENEZ DIAZ,DEPT GASTROENTEROL,AVENIDA REYES CATOLICOS 2,E-28040 MADRID,SPAIN

[2] HOFFMAN LA ROCHE,DEPT FARMA INVEST,MADRID,SPAIN

来源：

JOURNAL OF HEPATOLOGY | 1989年 / 8卷 / 03期

关键词：

D O I：

10.1016/0168-8278(89)90034-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：351 / 357

页数：7

共 16 条

[1]

BASSENDINE MF, 1981, GASTROENTEROLOGY, V80, P1016

[2]

GAUCI L, 1987, INT J CANCER S, V1, P21

[3] RECOMBINANT LEUKOCYTE-A INTERFERON - PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGIC EFFECTS IN CANCER-PATIENTS [J].

GUTTERMAN, JU ;

FINE, S ;

QUESADA, J ;

HORNING, SJ ;

LEVINE, JF ;

ALEXANIAN, R ;

BERNHARDT, L ;

KRAMER, M ;

SPIEGEL, H ;

COLBURN, W ;

TROWN, P ;

MERIGAN, T ;

DZIEWANOWSKI, Z .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :549-556

[4] THE DETECTION OF ANTIBODIES TO RECOMBINANT INTERFERON ALFA-2A IN HUMAN-SERUM [J].

HENNES, U ;

JUCKER, W ;

FISCHER, EA ;

KRUMMENACHER, T ;

PALLERONI, AV ;

TROWN, PW ;

LINDERCICCOLUNGHI, S ;

RAINISIO, M .

JOURNAL OF BIOLOGICAL STANDARDIZATION, 1987, 15 (03) :231-244

[5]

ITRI LM, 1987, CANCER, V59, P668, DOI 10.1002/1097-0142(19870201)59:3+<668::AID-CNCR2820591317>3.0.CO

[6]

2-J

[7]

JONES GJ, 1986, CANCER, V57, P1709, DOI 10.1002/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO

[8]

2-F

[9] NEUTRALIZATION OF INTERFERON BY ANTIBODY - APPRAISALS OF METHODS OF DETERMINING AND EXPRESSING THE NEUTRALIZATION TITER [J].

KAWADE, Y ;

WATANABE, Y .

JOURNAL OF INTERFERON RESEARCH, 1984, 4 (04) :571-584

[10]

LABANDA F, 1988, LANCET, V1, P250

← 1 2 →